Manager, Investor Relations and Corporate Communications

Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, which may be a promising option for patients with cancer. Overview The Manager, Investor Relations and Corporate Communications, will help drive high-impact communications across investors, media, employees, and other key stakeholders. Reporting to the Senior Director, Corporate Communications, and partnering closely with the Investor Relations and Corporate Communications team, this role will turn company strategy, milestones, and data into clear, compelling communications that support investor engagement, corporate visibility, and internal alignment. This is a hands-on, execution-oriented role for a strong communicator who thrives in a fast-moving public company environment. The ideal candidate brings curiosity, financial acumen, strong project management skills, and the ability to move quickly from insight to action while supporting executive communications, investor engagement, and commercial-stage biotechnology operations. Essential Functions and R